Shockwave Medical Reports First Quarter 2020 Financial Results

Go back to Shockwave Medical Reports First Quarter 2020 Financial Results

Shockwave Medical (SWAV) Misses Q1 EPS by 10c, Revenues Beat

May 12, 2020 4:20 PM EDT

Shockwave Medical (NASDAQ: SWAV) reported Q1 EPS of ($0.59), $0.10 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $14.17 million.

Recent Highlights

Recognized revenue of $15.2 million for the first quarter of 2020, representing an increase of 109% over the first quarter of 2019Completed enrollment in CAD III study of IVL for coronary use in the U.S.Completed enrollment in CAD IV pivotal study of IVL for coronary use in JapanExtended... More